Dr. Mark Lambrecht
Global Director, Health Care and Life Sciences
Dr. Mark Lambrecht has more than 20 years of experience studying and implementing the potential, use and future of analytics, artificial intelligence and data engineering to advance patient outcomes. He is responsible for the global health care and life sciences market strategy of SAS. Mark likes to discuss how leaders in government, hospitals, payers and pharmaceutical manufacturers can take AI, real world evidence and digital healthcare from hype to reality, without oversimplifying clinical, financial and operational complexity.
Prior to joining SAS, Mark worked in the pharmaceutical industry and studied at the KU Leuven, Belgium and at Stanford University, USA. He holds a PhD and Master in Bioscience Genetic Engineering from the KU Leuven.
|2020||The future of Analytics in healthcare||Charleston, South Carolina, USA||South Eastern chapter of HFMA|
|2019||AI In The Age Of Digital Health: Hype Or Transformative, What Is It Now?||Belgium||5th Conference in Digital Health Duval Union Academy|
|2019||Digital Transformation in Health Care and Life Sciences||Basel, Switzerland||SAS Health and Life Sciences Executive Forum|
|2017||Proving the real world value of medicines||Paris, France||PhUSE|